Core Insights - The Chinese cosmetics market is undergoing a significant paradigm shift, moving from "scale expansion" to "quality leadership" as it surpasses a market size of 1 trillion yuan and domestic brands exceed international ones in sales [1] - HBN, a skincare brand that has filed for an IPO in Hong Kong, exemplifies this shift by focusing on "slow research-driven efficacy," providing a model for domestic brands aiming for high-end market penetration [1] Group 1: Market Trends - The transition of domestic cosmetics brands to high-end positioning is a notable trend, involving upgrades in brand positioning, product efficacy, and consumer perception [4] - HBN has capitalized on the rise of ingredient-focused consumers and the popularization of scientific skincare, playing a dual role in market education and category definition [4] Group 2: HBN's Product Development - HBN has pioneered the "early C, late A" skincare formula, launching successful products like the dual retinol night cream and brightening water, establishing itself in the high-end retinol market [5] - The brand's retinol skincare products and α-arbutin essence have ranked first in national sales for three consecutive years from 2022 to 2024, with cumulative sales of over 30 million units by the end of 2025 [5] Group 3: Consumer Engagement - HBN has accumulated over 4.6 million high-repeat purchase users, with average transaction values gradually increasing; its repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively [7] Group 4: Research and Development - HBN's commitment to "slow research" has built a systematic innovation capability, driving the brand towards high-end positioning [8] - The company has established a complete research loop from basic research to raw material innovation and efficacy verification, with a research team of 103 professionals across various fields [8][10] - HBN has published over 50 international SCI papers, ranking first among domestic skincare brands in terms of publications as the first author [8] Group 5: Efficacy Verification and Industry Contribution - HBN has developed a comprehensive "full-link multi-dimensional cross-validation system" for product efficacy, being the only Chinese skincare brand to conduct efficacy testing through international authoritative institutions [10] - The brand is also advocating for the establishment of a scientific evaluation system for cosmetic efficacy evidence, marking its transition from a market participant to a contributor to high-quality industry development [10] - This shift signifies HBN's role in defining industry standards and its commitment to high-end brand development through continuous investment in research and innovation [10]